BMJ9d
Impact of the COVID-19 pandemic on incidence of coronary heart disease in Bavaria, Germany: an analysis of health claims data
Background Inconsistent findings about the impact of the COVID-19 pandemic on cardiovascular disease diagnosis and ...
BMJ15d
Optimising management of moderate secondary mitral regurgitation: insights into pharmacological and interventional approaches
Secondary mitral regurgitation (SMR) is a complex and evolving challenge in the landscape of heart failure (HF) management. Although significant secondary MR has been widely recognised for its adverse ...
BMJ15d
Atrial arrhythmia and heart failure in adult patients with congenital heart disease: a retrospective cohort study
Background Atrial arrhythmias (AA) and heart failure (HF) are major causes of hospitalisation in adult congenital heart disease (ACHD). This study aimed to evaluate the temporal relationship between ...
BMJ5d
Left ventricular bands. A normal anatomical feature.
Discrete delicate fibromuscular structures crossing the cavity of the left ventricle were identified on morphological examination in 329 (48%) of 686 hearts from patients of all ages with congenital ...
BMJ15d
Five-minute heart rate variability can predict obstructive angiographic coronary disease
4 Department of Cardiothoracic Surgery, Royal Brompton Hospital and Imperial College, London, UK Correspondence to Dr Dipak Kotecha, Clinical Trials and Evaluation Unit, Royal Brompton Hospital, ...
BMJ11d
Successful transcatheter aortic valve implantation (TAVI) is associated with transient left ventricular dysfunction
King's College London BHF Centre of Excellence, Department of Cardiology, King's College Hospital, London, UK Correspondence to Dr Philip MacCarthy, Consultant Cardiologist, Department of Cardiology, ...
BMJ12d
Percutaneous coronary intervention for stable coronary artery disease
The adverse consequences of stable coronary artery disease (CAD) are death, myocardial infarction (MI) and angina. Trials in stable CAD show that percutaneous coronary intervention (PCI) does not ...
BMJ10d
Transcatheter valve replacement in congenital heart disease: the present and the future
Correspondence to Dr Joanna Ghobrial, Cleveland Clinic Adult Congenital Heart Disease Center, Cleveland Clinic Foundation, Cleveland, OH, USA; joannaghobrial{at}gmail.com Familiarise the reader with ...
BMJ5d
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data
Dr F M Turazza, GISSI Coordinating Centre, Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milan, Italydepcardio{at}irfmn.mnegri.it ...
BMJ4d
Impact of different immunosuppressive drugs on QT interval in renal transplant patients
Introduction Kidney transplantation is the treatment of choice for most patients with end-stage renal disease (ESRD). Strategies to increase donor organ availability and to prolong the transplanted ...
BMJ15d
Timing of intervention in aortic stenosis: a review of current and future strategies
Correspondence to Dr Russell James Everett, BHF/Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4SB, UK; russell.everett{at}ed.ac.uk To review the pathophysiology of ...
BMJ6d
The natural history of acute myocardial infarction
Dr RM Norris, Royal Sussex County Hospital, Eastern Road, Brighton, East Sussex BN2 5BE, UK If you wish to reuse any or all of this article please use the link below ...